Artificial intelligence (AI) is swiftly transforming the healthcare landscape. A notable example is the large Chinese medicine model developed by Huawei Cloud in partnership with Tianjin Tasly Pharmaceutical, which has garnered prestigious certification. Ruijin Hospital has leveraged AI to boost the efficiency of pathological diagnosis by a staggering factor of a hundred. Furthermore, Medical Data Intelligence has successfully implemented intelligent platforms in numerous leading hospitals. This medical revolution has transcended the confines of laboratories, deeply penetrating every facet of diagnosis and treatment. The synergy of capital and technology is propelling publicly listed companies, such as Eastcom Software and Winning Health, to expedite their strategic layouts, while simultaneously catalyzing transformative changes in the R&D models of innovative enterprises like BioMap and RDI. The concerted efforts of multiple stakeholders are accelerating the formation of an industrial closed loop that encompasses technology, resources, and standards.
